0001562180-18-000299.txt : 20180112 0001562180-18-000299.hdr.sgml : 20180112 20180112160759 ACCESSION NUMBER: 0001562180-18-000299 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180110 FILED AS OF DATE: 20180112 DATE AS OF CHANGE: 20180112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kanes Stephen CENTRAL INDEX KEY: 0001612859 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36544 FILM NUMBER: 18526069 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sage Therapeutics, Inc. CENTRAL INDEX KEY: 0001597553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-299-8380 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-01-10 false 0001597553 Sage Therapeutics, Inc. SAGE 0001612859 Kanes Stephen C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 false true false false Chief Medical Officer Common Stock 2018-01-10 4 S false 600.00 170.67 D 46348.00 D Common Stock 2018-01-10 4 S false 1200.00 171.80 D 45148.00 D Common Stock 2018-01-10 4 S false 1200.00 173.09 D 43948.00 D Common Stock 2018-01-10 4 S false 2200.00 174.35 D 41748.00 D Common Stock 2018-01-10 4 S false 2461.00 175.03 D 39287.00 D Common Stock 2018-01-10 4 S false 11057.00 176.53 D 28230.00 D Common Stock 2018-01-10 4 S false 9100.00 177.48 D 19130.00 D Common Stock 2018-01-10 4 S false 6923.00 178.33 D 12207.00 D Common Stock 2018-01-10 4 S false 7859.00 179.61 D 4348.00 D Common Stock 2018-01-10 4 S false 1400.00 180.11 D 2948.00 D Common Stock 2018-01-12 4 M false 20000.00 0.45 A 22948.00 D Stock Option (Right to Buy) 0.45 2018-01-12 4 M false 20000.00 0.00 D 2023-07-23 Common Stock 20000.00 111432.00 D The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. This transaction was executed in multiple trades at prices ranging from $170.12 USD to $171.02 USD. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $171.41 USD to $172.27 USD. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $172.68 USD to $173.49 USD. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $173.73 USD to $174.72 USD. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $174.84 USD to $175.78 USD. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $175.94 USD to $176.84 USD. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $176.99 USD to $177.98 USD. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $177.99 USD to $178.89 USD. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $178.99 USD to $179.98 USD. The price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $179.99 USD to $180.44 USD. The price reported above reflects the weighted average sale price. The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2011 Stock Option and Incentive Plan. The option fully vested on July 18, 2017, subject to continued service through such date. /s/ Anne Marie Cook as Attorney-in-Fact for Stephen Kanes 2018-01-10